HCG Appoints Dr. Manish Mattoo as Interim CFO Amid Strong Financial Growth
Healthcare Global Enterprises Limited (HCG) has appointed Dr. Manish Mattoo, its Executive Director and CEO, as interim Chief Financial Officer effective December 01, 2025. This appointment comes during a period of robust financial growth for the company. HCG's total assets have increased by 30.87% year-over-year to ₹3,543.20 cr, with significant growth in fixed assets (38.89%) and current assets (24.11%). Dr. Mattoo, with over two decades of healthcare business leadership experience, will serve in this role until a new CFO is appointed by the Board of Directors.
*this image is generated using AI for illustrative purposes only.
Healthcare Global Enterprises Limited (HCG), a leading provider of cancer care services in India, has announced a significant leadership change amidst a period of robust financial growth. The company has appointed Dr. Manish Mattoo, its Executive Director and CEO, as the interim Chief Financial Officer, effective December 01, 2025.
Key Highlights
- Dr. Manish Mattoo appointed as interim CFO
- Appointment effective from December 01, 2025
- Role to continue until a new CFO is appointed by the Board of Directors
- Dr. Mattoo brings over two decades of healthcare business leadership experience
Financial Performance
The appointment comes at a time when HCG is showing strong financial performance. Based on the company's latest balance sheet data, HCG has demonstrated significant growth across various financial metrics:
| Financial Metric | Current Year (2025-03) | 1 Year Ago (2024-03) | % Change |
|---|---|---|---|
| Total Assets | ₹3,543.20 cr | ₹2,707.50 cr | 30.87% |
| Current Assets | ₹843.80 cr | ₹679.90 cr | 24.11% |
| Fixed Assets | ₹2,441.90 cr | ₹1,758.20 cr | 38.89% |
| Total Equity | ₹990.00 cr | ₹865.10 cr | 14.44% |
The company's total assets have grown by 30.87% year-over-year, reaching ₹3,543.20 cr. This growth is supported by a 38.89% increase in fixed assets and a 24.11% rise in current assets, indicating significant investments in the company's operational capacity.
Leadership Transition
Dr. Manish Mattoo's appointment as interim CFO comes with a wealth of experience in the healthcare sector. With over two decades of multifaceted experience in healthcare business leadership, Dr. Mattoo is well-positioned to guide HCG's financial strategies during this transition period.
The company stated that Dr. Mattoo will serve in this role until a new Chief Financial Officer is appointed by the Board of Directors. This move ensures continuity in financial leadership and strategic decision-making during the search for a permanent CFO.
Looking Ahead
As HCG continues its growth trajectory, the appointment of Dr. Mattoo as interim CFO is expected to provide stability and strategic financial guidance. The company's strong financial performance, coupled with experienced leadership, positions HCG well for continued success in the competitive healthcare sector.
Investors and stakeholders will be watching closely to see how this leadership change impacts HCG's financial strategies and performance in the coming quarters.
